Market Watch – Page 567 – Biotech Insider

All Posts in "Market Watch"

Microsoft earnings: Trillion-dollar valuation is banking on continuing cloud growth

One analyst sees cloud accounting for 60% of Microsoft’s revenue in six years

by Editor — July 13, 2019 By Editor in Market Watch

Snap’s ‘viral’ filters earn the stock more love from Wall Street

Ahead of second-quarter report, Goldman upgrades Snap due to user-growth momentum

by Editor — July 13, 2019 By Editor in Market Watch

S&P 500, Dow, Nasdaq close at record levels again as bulls bank on Fed rate cut

S&P 500 scores fourth straight day of gains

by Editor — July 13, 2019 By Editor in Market Watch

Uber and Lyft are pushing the online grocery business underground

One executive forecasts that more than 60% of groceries will be bought online by 2025

by Editor — July 13, 2019 By Editor in Market Watch

30-year Treasury yield hits nearly six-week high after ‘borderline shocking’ debt auction

Yield curve extends steepening in wake of CPI data

by Editor — July 12, 2019 By Editor in Market Watch

Farmers are stockpiling corn in response to tough growing conditions, waiting for higher prices

‘They’ll be just as hungry for corn in August,’ one said

by Editor — July 12, 2019 By Editor in Market Watch

U.S. runs June budget deficit of $8 billion

Shortfall widens to $747 billion for fiscal year to date, Treasury says

by Editor — July 12, 2019 By Editor in Market Watch

Dow, S&P end in record territory after Powell boosts expectations for Fed rate cut

UnitedHealth shares lead the Dow higher

by Editor — July 12, 2019 By Editor in Market Watch

Nio’s stock keeps rising toward its best-ever 6-day run

Shares have rallied 45% in a week after China auto sales data, upbeat Tesla delivery report

by Editor — July 11, 2019 By Editor in Market Watch

Branson’s ‘space’ stock is the latest sign of market euphoria

Virgin Galactic jumps on stock market boom, and Brett Arends brings investors down to Earth

by Editor — July 11, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.